# Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

> **NCT00080873** · NA · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 195 (actual)

## Conditions studied

- Kidney Cancer
- Leukemia
- Lymphoma
- Neuroblastoma
- Oral Complications
- Sarcoma

## Interventions

- **DRUG:** Traumeel S
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00080873
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-11
- **Final completion:** 2011-01
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2016-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080873, "Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00080873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*